299 related articles for article (PubMed ID: 10401560)
1. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.
Wegener JW; Closs EI; Förstermann U; Nawrath H
Br J Pharmacol; 1999 Jun; 127(3):693-700. PubMed ID: 10401560
[TBL] [Abstract][Full Text] [Related]
2. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
3. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
Sandirasegarane L; Diamond J
J Mol Cell Cardiol; 1999 Apr; 31(4):799-808. PubMed ID: 10329207
[TBL] [Abstract][Full Text] [Related]
4. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
Wegener JW; Gath I; Förstermann U; Nawrath H
Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
[TBL] [Abstract][Full Text] [Related]
5. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
Brunner F; Schmidt K; Nielsen EB; Mayer B
J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
7. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
[TBL] [Abstract][Full Text] [Related]
8. Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient mice.
Wegener JW; Gödecke A; Schrader J; Nawrath H
Br J Pharmacol; 2002 Jun; 136(3):415-20. PubMed ID: 12023944
[TBL] [Abstract][Full Text] [Related]
9. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
10. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
12. Modulation of relaxation to levcromakalim by S-nitroso-N-acetylpenicillamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1998 Jul; 124(6):1219-26. PubMed ID: 9720794
[TBL] [Abstract][Full Text] [Related]
13. Cyclic GMP-independent relaxation of rat pulmonary artery by spermine NONOate, a diazeniumdiolate nitric oxide donor.
Homer KL; Wanstall JC
Br J Pharmacol; 2000 Oct; 131(4):673-82. PubMed ID: 11030715
[TBL] [Abstract][Full Text] [Related]
14. Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels.
Mulè F; D'Angelo S; Serio R
Br J Pharmacol; 1999 May; 127(2):514-20. PubMed ID: 10385253
[TBL] [Abstract][Full Text] [Related]
15. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
Onoue H; Katusic ZS
Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
[TBL] [Abstract][Full Text] [Related]
16. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
[TBL] [Abstract][Full Text] [Related]
17. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation.
Olson LJ; Knych ET; Herzig TC; Drewett JG
Hypertension; 1997 Jan; 29(1 Pt 2):254-61. PubMed ID: 9039111
[TBL] [Abstract][Full Text] [Related]
18. Cyclic GMP-dependent vasodilatory properties of LASSBio 294 in rat aorta.
Silva CL; Noël F; Barreiro EJ
Br J Pharmacol; 2002 Jan; 135(1):293-8. PubMed ID: 11786506
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of DETA-NONOate, a nitric oxide donor, on hydrogen peroxide-induced neurotoxicity in cortical neurones.
Fernández-Tomé P; Lizasoain I; Leza JC; Lorenzo P; Moro MA
Neuropharmacology; 1999 Sep; 38(9):1307-15. PubMed ID: 10471084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
